China Ophthalmic Devices Market Outlook to 2033 – Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “China Ophthalmic Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the China Ophthalmic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Ophthalmic Viscoelastic Devices (OVD), Intraocular Lens (IOL), Glaucoma Surgery Devices, Ophthalmic Lasers and Corneal Implants

The China Ophthalmic Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Ophthalmic Devices Market.
• Global corporate-level profiles of key companies operating within the China Ophthalmic Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Ophthalmic Devices is segmented as follows –

• Ophthalmic Viscoelastic Devices (OVD)

• Intraocular Lens (IOL)

• Glaucoma Surgery Devices

• Ophthalmic Lasers

• Corneal Implants

Reasons to Buy

Key Reasons to Purchase – The China Ophthalmic Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Carl Zeiss Meditec AG_x000D_
Alcon Inc_x000D_
Bausch & Lomb Inc_x000D_
Johnson & Johnson Vision Care Inc_x000D_
Glaukos Corp_x000D_
Hoya Corp_x000D_
SightLife_x000D_
Allergan Aesthetics

Table of Contents

1 Table of Contents_x000D_

1.1 List of Tables_x000D_

1.2 List of Figures_x000D_

2 Introduction_x000D_

2.1 What Is This Report About?_x000D_

2.2 Ophthalmic Devices Market Segmentation_x000D_

2.3 Definitions of Markets Covered in the Report_x000D_

3 Ophthalmic Devices Market, China_x000D_

3.1 Ophthalmic Devices Market, China, Revenue ($m), 2018-2033_x000D_

3.2 Ophthalmic Devices Market, China, Revenue Mix ($m), 2023_x000D_

3.3 Ophthalmic Devices Market, China, Category Contribution by Revenue ($m), 2023_x000D_

3.4 Ophthalmic Devices Market, China, Revenue ($m), 2018-2033_x000D_

3.5 Ophthalmic Devices Market, China, Volume (Units), 2018-2033_x000D_

3.6 Ophthalmic Devices Market, China, Volume (Units), 2018-2033_x000D_

3.7 Ophthalmic Devices Market, China, Company Share by Revenue ($m), 2023_x000D_

4 Corneal Implants Market, China_x000D_

4.1 Corneal Implants Market, China, Revenue Mix ($m), 2023_x000D_

4.2 Corneal Implants Market, China, Segment Contribution (%), 2023_x000D_

4.3 Corneal Implants Market, China, Revenue ($m), 2018-2033_x000D_

4.4 Corneal Implants Market, China, Volume (Units), 2018-2033_x000D_

4.5 Corneal Implants Market, China, Average Price ($), 2018-2033_x000D_

4.6 Corneal Implants Market, China, Distribution Share by Revenue ($m), 2023_x000D_

4.7 Corneal Implants Market, China, Company Share by Revenue ($m), 2023_x000D_

5 Glaucoma Surgery Devices Market, China_x000D_

5.1 Glaucoma Surgery Devices Market, China, Revenue Mix ($m), 2023_x000D_

5.2 Glaucoma Surgery Devices Market, China, Segment Contribution (%), 2023_x000D_

5.3 Glaucoma Surgery Devices Market, China, Revenue ($m), 2018-2033_x000D_

5.3.1 Glaucoma Drainage Devices Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

5.4 Glaucoma Surgery Devices Market, China, Volume (Units), 2018-2033_x000D_

5.4.1 Glaucoma Drainage Devices Market, China, Volume (Units), by Segment, 2018-2033_x000D_

5.5 Glaucoma Surgery Devices Market, China, Average Price ($), 2018-2033_x000D_

5.6 Glaucoma Surgery Devices Market, China, Distribution Share by Revenue ($m), 2023_x000D_

5.7 Glaucoma Surgery Devices Market, China, Company Share by Revenue ($m), 2023_x000D_

6 Intraocular Lens (IOL) Market, China_x000D_

6.1 Intraocular Lens (IOL) Market, China, Revenue Mix ($m), 2023_x000D_

6.2 Intraocular Lens (IOL) Market, China, Segment Contribution (%), 2023_x000D_

6.3 Intraocular Lens (IOL) Market, China, Revenue ($m), 2018-2033_x000D_

6.3.1 Foldable IOL Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

6.4 Intraocular Lens (IOL) Market, China, Volume (Units), 2018-2033_x000D_

6.4.1 Foldable IOL Market, China, Volume (Units), by Segment, 2018-2033_x000D_

6.5 Intraocular Lens (IOL) Market, China, Average Price ($) , 2018-2033_x000D_

6.6 Intraocular Lens (IOL) Market, China, Distribution Share by Revenue ($m), 2023_x000D_

6.7 Intraocular Lens (IOL) Market, China, Company Share by Revenue ($m), 2023_x000D_

7 Ophthalmic Lasers Market, China_x000D_

7.1 Ophthalmic Lasers Market, China, Revenue Mix ($m), 2023_x000D_

7.2 Ophthalmic Lasers Market, China, Segment Contribution (%), 2023_x000D_

7.3 Ophthalmic Lasers Market, China, Revenue ($m), 2018-2033_x000D_

7.4 Ophthalmic Lasers Market, China, Volume (Units), 2018-2033_x000D_

7.5 Ophthalmic Lasers Market, China, Average Price ($), 2018-2033_x000D_

7.6 Ophthalmic Lasers Market, China, Distribution Share by Revenue ($m), 2023_x000D_

7.7 Ophthalmic Lasers Market, China, Company Share by Revenue ($m), 2023_x000D_

8 Ophthalmic Viscoelastic Devices (OVD) Market, China_x000D_

8.1 Ophthalmic Viscoelastic Devices (OVD) Market, China, Revenue Mix ($m), 2023_x000D_

8.2 Ophthalmic Viscoelastic Devices (OVD) Market, China, Segment Contribution (%), 2023_x000D_

8.3 Ophthalmic Viscoelastic Devices (OVD) Market, China, Revenue ($m), 2018-2033_x000D_

8.4 Ophthalmic Viscoelastic Devices (OVD) Market, China, Volume (Units), 2018-2033_x000D_

8.5 Ophthalmic Viscoelastic Devices (OVD) Market, China, Average Price ($) , 2018-2033_x000D_

8.6 Ophthalmic Viscoelastic Devices (OVD) Market, China, Distribution Share by Revenue ($m), 2023_x000D_

8.7 Ophthalmic Viscoelastic Devices (OVD) Market, China, Company Share by Revenue ($m), 2023_x000D_

9 Overview of Key Companies in China, Ophthalmic Devices Market_x000D_

9.1 Carl Zeiss Meditec AG_x000D_

9.1.1 Company Overview_x000D_

9.2 Alcon Inc_x000D_

9.2.1 Company Overview_x000D_

9.3 Glaukos Corp_x000D_

9.3.1 Company Overview_x000D_

9.4 Johnson & Johnson Vision Care Inc_x000D_

9.4.1 Company Overview_x000D_

9.5 Bausch & Lomb Inc_x000D_

9.5.1 Company Overview_x000D_

9.6 Allergan Aesthetics_x000D_

9.6.1 Company Overview_x000D_

9.7 SightLife_x000D_

9.7.1 Company Overview_x000D_

9.8 Aurolab_x000D_

9.8.1 Company Overview_x000D_

9.9 Hoya Corp_x000D_

9.9.1 Company Overview_x000D_

9.10 Santen Pharmaceutical Co Ltd_x000D_

9.10.1 Company Overview_x000D_

10 Ophthalmic Devices Market Pipeline Products_x000D_

11 Financial Deals Landscape_x000D_

11.1 Equity Offerings_x000D_

11.1.1 Eyebright Medical Technology Announces Private Placement of Shares_x000D_

11.1.2 QITIAN Technology Group to Raise USD5.5 Million in Private Placement of Shares_x000D_

11.2 Venture Financing_x000D_

11.2.1 Suzhou Jishi Medical Technology Raises Funds through Pre-Series A Financing_x000D_

11.2.2 Sigma Squares (Beijing) Tech (Square and, FangCheng) Raises Funds through Series B Financing_x000D_

11.2.3 Medco Technology Secures USD28.17 Million in Series B Financing_x000D_

11.2.4 Sieran Medical Raises USD14.05 Million in Venture Financing_x000D_

11.2.5 Health Guard Biomed (Suzhou) Biomedical Technology (HisGate, Hisgade, Haisigaide Biomedical Technology Group) Raises Funds through Venture Financing_x000D_

11.2.6 Tupai (Beijing) Medical Technology Secures USD27.50 Series D Investment_x000D_

11.2.7 Beijing Xianwei Medical Technology Raises Funds through Series A Financing_x000D_

11.2.8 Changchun Changguang Chenying Biological Science Instrument (Changguang Chenying) Secures Series A Financing_x000D_

11.2.9 Shanghai Chenkai Jingshi Optical (Chenkai Jingshi) Secures Pre-Series A Venture Funding_x000D_

11.2.10 Zhongjing Vision (Suzhou) Optical Technology Secures Pre Series A Financing_x000D_

11.2.11 Suzhou Bigway Medical Technology Raises USD4.14 Million in Venture Financing_x000D_

11.2.12 Bigway Medical Secures USD0.69 Million in Series B Financing_x000D_

11.2.13 Shiwei Imaging (Henan) Technology (Intalight Saiwei) Secures USD13.82 Million Series D Funding_x000D_

11.2.14 Tianchen Tianjin Biotechnology (Tianchen Biotechnology) Secures USD13.86 Million in Series A+ Financing_x000D_

11.2.15 Suzhou Weiqing Medical Equipment (Weiqing Medical) Raises USD13.86 Million in Series D Financing_x000D_

11.2.16 Sinoma Advanced Materials Raises Funds in Venture Financing_x000D_

11.2.17 Shenzhen Dashi City Optical Technology Raises Fund through Series A+ Financing_x000D_

11.2.18 ATV Health Technology Raises Funds through Pre-A Series Financing_x000D_

11.2.19 Diluo Medical Devices Secures Series C Financing_x000D_

12 Recent Developments_x000D_

12.1 Corporate Communications_x000D_

12.1.1 Jun 07, 2024: Tianjin TEDA Biomedical Engineering Notice of AGM_x000D_

12.1.2 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA)_x000D_

12.1.3 Jan 29, 2024: Shanghai Conant Optical Co.: Proposed Re-election and Appointment of Supervisors_x000D_

12.2 Financial Announcements_x000D_

12.2.1 Dec 04, 2024: Foshan SOCO Precision Instrument Receives 510(K) Clearance ForHigh-Speed Air Turbine Handpiece Model – SCHF22_x000D_

12.2.2 Dec 04, 2024: Hangzhou Clongene Biotech Receives CLIA Approval For CLUNGENE Fentanyl Home Test Cassette_x000D_

12.2.3 Aug 22, 2024: Eyebright Medical Technology Reports Financial Results for H1 of 2024_x000D_

12.2.4 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-ST-C Dental Zirconia Block_x000D_

12.2.5 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-3D-Pro ML Dental Zirconia Block_x000D_

12.2.6 May 06, 2024: Huizhou Foryou Medical Devices Receives An Additional 510(k) Clearance For LUOFUCON Collagen Wound Dressing_x000D_

12.2.7 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA)_x000D_

12.2.8 Apr 22, 2024: Biovis Vascular Biological Mesh Was Approved for Registration_x000D_

12.3 Other Significant Developments_x000D_

12.3.1 Feb 21, 2024: AmoyDx PD-L1 (E1L3N) assay gained the priority recommendation from Chinese expert consensus_x000D_

12.4 Product News_x000D_

12.4.1 Jan 31, 2024: WuXi AppTec : New Blow-Fill-Seal Aseptic Filling Line_x000D_

12.5 Strategy And Business Planning_x000D_

12.5.1 Mar 22, 2024: Guangzhou Xinbo Electronic Received Additional FDA 510(K) Clearance For Pain Therapy Device_x000D_

13 Appendix_x000D_

13.1 Research Methodology_x000D_

13.1.1 Coverage_x000D_

13.1.2 Secondary Research_x000D_

13.1.3 Primary Research_x000D_

13.1.4 Market Modeling and Forecasting_x000D_

13.1.5 Company Share Analysis_x000D_

13.1.6 Distribution Share Analysis_x000D_

13.1.7 Benchmarking_x000D_

13.2 GlobalData Consulting_x000D_

13.3 Contact Us_x000D_

13.4 Disclaimer

Table

Table 1: Ophthalmic Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 2: Ophthalmic Devices Market, China, Category Contribution by Revenue ($m), 2023

Table 3: Ophthalmic Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 4: Ophthalmic Devices Market, China, Volume (Units), 2018-2033

Table 5: Ophthalmic Devices Market, China, Volume (Units), 2018-2033

Table 6: Ophthalmic Devices Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 7: Corneal Implants Market, China, Segment Contribution (%), 2023

Table 8: Corneal Implants Market, China, Revenue ($m), USD Constant, 2018-2033

Table 9: Corneal Implants Market, China, Volume (Units), 2018-2033

Table 10: Corneal Implants Market, China, Average Price ($), 2018-2033

Table 11: Corneal Implants Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 12: Corneal Implants Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 13: Glaucoma Surgery Devices Market, China, Segment Contribution (%), 2023

Table 14: Glaucoma Surgery Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 15: Glaucoma Drainage Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 16: Glaucoma Surgery Devices Market, China, Volume (Units), 2018-2033

Table 17: Glaucoma Drainage Devices Market, China, Volume (Units), 2018-2033

Table 18: Glaucoma Surgery Devices Market, China, Average Price ($), 2018-2033

Table 19: Glaucoma Surgery Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 20: Glaucoma Surgery Devices Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 21: Intraocular Lens (IOL) Market, China, Segment Contribution (%), 2023

Table 22: Intraocular Lens (IOL) Market, China, Revenue ($m), USD Constant, 2018-2033

Table 23: Foldable IOL Market, China, Revenue ($m), USD Constant, 2018-2033

Table 24: Intraocular Lens (IOL) Market, China, Volume (Units), 2018-2033

Table 25: Foldable IOL Market, China, Volume (Units), 2018-2033

Table 26: Intraocular Lens (IOL) Market, China, Average Price ($), 2018-2033

Table 27: Intraocular Lens (IOL) Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 28: Intraocular Lens (IOL) Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 29: Ophthalmic Lasers Market, China, Segment Contribution (%), 2023

Table 30: Ophthalmic Lasers Market, China, Revenue ($m), USD Constant, 2018-2033

Table 31: Ophthalmic Lasers Market, China, Volume (Units), 2018-2033

Table 32: Ophthalmic Lasers Market, China, Average Price ($), 2018-2033

Table 33: Ophthalmic Lasers Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 34: Ophthalmic Lasers Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 35: Ophthalmic Viscoelastic Devices (OVD) Market, China, Segment Contribution (%), 2023

Table 36: Ophthalmic Viscoelastic Devices (OVD) Market, China, Revenue ($m), USD Constant, 2018-2033

Table 37: Ophthalmic Viscoelastic Devices (OVD) Market, China, Volume (Units), 2018-2033

Table 38: Ophthalmic Viscoelastic Devices (OVD) Market, China, Average Price ($), 2018-2033

Table 39: Ophthalmic Viscoelastic Devices (OVD) Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 40: Ophthalmic Viscoelastic Devices (OVD) Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 41: Ophthalmic Devices Market Pipeline Products

Table 42: Eyebright Medical Technology Announces Private Placement of Shares

Table 43: QITIAN Technology Group to Raise USD5.5 Million in Private Placement of Shares

Table 44: Suzhou Jishi Medical Technology Raises Funds through Pre-Series A Financing

Table 45: Sigma Squares (Beijing) Tech (Square and, FangCheng) Raises Funds through Series B Financing

Table 46: Medco Technology Secures USD28.17 Million in Series B Financing

Table 47: Sieran Medical Raises USD14.05 Million in Venture Financing

Table 48: Health Guard Biomed (Suzhou) Biomedical Technology (HisGate, Hisgade, Haisigaide Biomedical Technology Group) Raises Funds through Venture Financing

Table 49: Tupai (Beijing) Medical Technology Secures USD27.50 Series D Investment

Table 50: Beijing Xianwei Medical Technology Raises Funds through Series A Financing

Table 51: Changchun Changguang Chenying Biological Science Instrument (Changguang Chenying) Secures Series A Financing

Table 52: Shanghai Chenkai Jingshi Optical (Chenkai Jingshi) Secures Pre-Series A Venture Funding

Table 53: Zhongjing Vision (Suzhou) Optical Technology Secures Pre Series A Financing

Table 54: Suzhou Bigway Medical Technology Raises USD4.14 Million in Venture Financing

Table 55: Bigway Medical Secures USD0.69 Million in Series B Financing

Table 56: Shiwei Imaging (Henan) Technology (Intalight Saiwei) Secures USD13.82 Million Series D Funding

Table 57: Tianchen Tianjin Biotechnology (Tianchen Biotechnology) Secures USD13.86 Million in Series A+ Financing

Table 58: Suzhou Weiqing Medical Equipment (Weiqing Medical) Raises USD13.86 Million in Series D Financing

Table 59: Sinoma Advanced Materials Raises Funds in Venture Financing

Table 60: Shenzhen Dashi City Optical Technology Raises Fund through Series A+ Financing

Table 61: ATV Health Technology Raises Funds through Pre-A Series Financing

Table 62: Diluo Medical Devices Secures Series C Financing

Table 63: Total Number of Primary Research Participants, Ophthalmic Devices Market, by Country

Figures

Figure 1: Ophthalmic Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 2: Ophthalmic Devices Market, China, Revenue Mix ($m), 2023

Figure 3: Ophthalmic Devices Market, China, Category Contribution (%), 2023

Figure 4: Ophthalmic Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 5: Ophthalmic Devices Market, China, Volume (Units), 2018-2033

Figure 6: Ophthalmic Devices Market, China, Volume (Units), 2018-2033

Figure 7: Ophthalmic Devices Market, China, Company Share (%) 2023

Figure 8: Corneal Implants Market, China, Revenue Mix ($m), 2023

Figure 9: Corneal Implants Market, China, Segment Contribution (%), 2023

Figure 10: Corneal Implants Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 11: Corneal Implants Market, China, Volume (Units), 2018-2033

Figure 12: Corneal Implants Market, China, Company Share (%) 2023

Figure 13: Glaucoma Surgery Devices Market, China, Revenue Mix ($m), 2023

Figure 14: Glaucoma Surgery Devices Market, China, Segment Contribution (%), 2023

Figure 15: Glaucoma Surgery Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 16: Glaucoma Drainage Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 17: Glaucoma Surgery Devices Market, China, Volume (Units), 2018-2033

Figure 18: Glaucoma Drainage Devices Market, China, Volume (Units), 2018-2033

Figure 19: Glaucoma Surgery Devices Market, China, Company Share (%) 2023

Figure 20: Intraocular Lens (IOL) Market, China, Revenue Mix ($m), 2023

Figure 21: Intraocular Lens (IOL) Market, China, Segment Contribution (%), 2023

Figure 22: Intraocular Lens (IOL) Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 23: Foldable IOL Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 24: Intraocular Lens (IOL) Market, China, Volume (Units), 2018-2033

Figure 25: Foldable IOL Market, China, Volume (Units), 2018-2033

Figure 26: Intraocular Lens (IOL) Market, China, Company Share (%) 2023

Figure 27: Ophthalmic Lasers Market, China, Revenue Mix ($m), 2023

Figure 28: Ophthalmic Lasers Market, China, Segment Contribution (%), 2023

Figure 29: Ophthalmic Lasers Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 30: Ophthalmic Lasers Market, China, Volume (Units), 2018-2033

Figure 31: Ophthalmic Lasers Market, China, Company Share (%) 2023

Figure 32: Ophthalmic Viscoelastic Devices (OVD) Market, China, Revenue Mix ($m), 2023

Figure 33: Ophthalmic Viscoelastic Devices (OVD) Market, China, Segment Contribution (%), 2023

Figure 34: Ophthalmic Viscoelastic Devices (OVD) Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 35: Ophthalmic Viscoelastic Devices (OVD) Market, China, Volume (Units), 2018-2033

Figure 36: Ophthalmic Viscoelastic Devices (OVD) Market, China, Company Share (%) 2023

China Ophthalmic Devices Market Outlook to 2033 – Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at China Ophthalmic Devices Market Outlook to 2033 – Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others in real time.

  • Access a live China Ophthalmic Devices Market Outlook to 2033 – Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.